Cohn SL - Search Results

1

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Zage PE, Louis CU, Cohn SL. Zage PE, et al. Among authors: cohn sl. Pediatr Blood Cancer. 2012 Jul 1;58(7):1099-105. doi: 10.1002/pbc.24116. Epub 2012 Feb 29. Pediatr Blood Cancer. 2012. PMID: 22378620 Free PMC article. Review.

2

Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.

Cohn SL, Salwen H, Herst CV, Maurer HS, Nieder ML, Morgan ER, Rosen ST. Cohn SL, et al. Cancer. 1988 Aug 15;62(4):723-6. doi: 10.1002/1097-0142(19880815)62:4<723::aid-cncr2820620413>3.0.co;2-u. Cancer. 1988. PMID: 3395955

3

Advances in the diagnosis and treatment of neuroblastoma.

Katzenstein HM, Cohn SL. Katzenstein HM, et al. Among authors: cohn sl. Curr Opin Oncol. 1998 Jan;10(1):43-51. doi: 10.1097/00001622-199801000-00008. Curr Opin Oncol. 1998. PMID: 9466484 Review.

4

Positive association between congenital anomalies and risk of neuroblastoma.

Menegaux F, Olshan AF, Reitnauer PJ, Blatt J, Cohn SL. Menegaux F, et al. Among authors: cohn sl. Pediatr Blood Cancer. 2005 Oct 15;45(5):649-55. doi: 10.1002/pbc.20263. Pediatr Blood Cancer. 2005. PMID: 15547919

5

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

Yang Q, Zage P, Kagan D, Tian Y, Seshadri R, Salwen HR, Liu S, Chlenski A, Cohn SL. Yang Q, et al. Among authors: cohn sl. Clin Cancer Res. 2004 Dec 15;10(24):8493-500. doi: 10.1158/1078-0432.CCR-04-1331. Clin Cancer Res. 2004. PMID: 15623630

6

Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.

Liu S, Tian Y, Chlenski A, Yang Q, Zage P, Salwen HR, Crawford SE, Cohn SL. Liu S, et al. Among authors: cohn sl. Am J Pathol. 2005 Mar;166(3):891-900. doi: 10.1016/S0002-9440(10)62309-7. Am J Pathol. 2005. PMID: 15743800 Free PMC article.

7

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.

London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B. London WB, et al. Among authors: cohn sl. Cancer Lett. 2005 Oct 18;228(1-2):257-66. doi: 10.1016/j.canlet.2004.12.054. Cancer Lett. 2005. PMID: 16024170 Review.

8

SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.

Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL. Chlenski A, et al. Among authors: cohn sl. Int J Cancer. 2006 Jan 15;118(2):310-6. doi: 10.1002/ijc.21357. Int J Cancer. 2006. PMID: 16052522 Free article.

9

Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day.

Grupp SA, Cohn SL, Wall D, Reynolds CP; Hematopoietic Stem Cell Transplant Discipline and the Neuroblastoma Disease Committee, Children's Oncology Group. Grupp SA, et al. Among authors: cohn sl. Pediatr Blood Cancer. 2006 Jun;46(7):719-22. doi: 10.1002/pbc.20769. Pediatr Blood Cancer. 2006. PMID: 16429413 Review.

10

Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.

Burke MJ, Cohn SL. Burke MJ, et al. Among authors: cohn sl. Pediatr Blood Cancer. 2008 Mar;50(3):679-80. doi: 10.1002/pbc.21009. Pediatr Blood Cancer. 2008. PMID: 16900484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page